Cargando…

Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus

ABSTRACT: Early detection of esophageal neoplasia enables curative endoscopic therapy, but the current diagnostic standard of care has low sensitivity because early neoplasia is often inconspicuous with conventional white-light endoscopy. Here, we hypothesized that spectral endoscopy could enhance c...

Descripción completa

Detalles Bibliográficos
Autores principales: Waterhouse, Dale J., Januszewicz, Wladyslaw, Ali, Sharib, Fitzgerald, Rebecca C., di Pietro, Massimiliano, Bohndiek, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611389/
https://www.ncbi.nlm.nih.gov/pubmed/34039635
http://dx.doi.org/10.1158/0008-5472.CAN-21-0474
_version_ 1783605273629294592
author Waterhouse, Dale J.
Januszewicz, Wladyslaw
Ali, Sharib
Fitzgerald, Rebecca C.
di Pietro, Massimiliano
Bohndiek, Sarah E.
author_facet Waterhouse, Dale J.
Januszewicz, Wladyslaw
Ali, Sharib
Fitzgerald, Rebecca C.
di Pietro, Massimiliano
Bohndiek, Sarah E.
author_sort Waterhouse, Dale J.
collection PubMed
description ABSTRACT: Early detection of esophageal neoplasia enables curative endoscopic therapy, but the current diagnostic standard of care has low sensitivity because early neoplasia is often inconspicuous with conventional white-light endoscopy. Here, we hypothesized that spectral endoscopy could enhance contrast for neoplasia in surveillance of patients with Barrett's esophagus. A custom spectral endoscope was deployed in a pilot clinical study of 20 patients to capture 715 in vivo tissue spectra matched with gold standard diagnosis from histopathology. Spectral endoscopy was sensitive to changes in neovascularization during the progression of disease; both non-dysplastic and neoplastic Barrett's esophagus showed higher blood volume relative to healthy squamous tissue (P = 0.001 and 0.02, respectively), and vessel radius appeared larger in neoplasia relative to non-dysplastic Barrett's esophagus (P = 0.06). We further developed a deep learning algorithm capable of classifying spectra of neoplasia versus non-dysplastic Barrett's esophagus with high accuracy (84.8% accuracy, 83.7% sensitivity, 85.5% specificity, 78.3% positive predictive value, and 89.4% negative predictive value). Exploiting the newly acquired library of labeled spectra to model custom color filter sets identified a potential 12-fold enhancement in contrast between neoplasia and non-dysplastic Barrett's esophagus using application-specific color filters compared with standard-of-care white-light imaging (perceptible color difference = 32.4 and 2.7, respectively). This work demonstrates the potential of endoscopic spectral imaging to extract vascular properties in Barrett's esophagus, to classify disease stages using deep learning, and to enable high-contrast endoscopy. SIGNIFICANCE: The results of this pilot first-in-human clinical trial demonstrate the potential of spectral endoscopy to reveal disease-associated vascular changes and to provide high-contrast delineation of neoplasia in the esophagus.
format Online
Article
Text
id pubmed-7611389
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-76113892021-12-15 Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus Waterhouse, Dale J. Januszewicz, Wladyslaw Ali, Sharib Fitzgerald, Rebecca C. di Pietro, Massimiliano Bohndiek, Sarah E. Cancer Res Convergence and Technologies ABSTRACT: Early detection of esophageal neoplasia enables curative endoscopic therapy, but the current diagnostic standard of care has low sensitivity because early neoplasia is often inconspicuous with conventional white-light endoscopy. Here, we hypothesized that spectral endoscopy could enhance contrast for neoplasia in surveillance of patients with Barrett's esophagus. A custom spectral endoscope was deployed in a pilot clinical study of 20 patients to capture 715 in vivo tissue spectra matched with gold standard diagnosis from histopathology. Spectral endoscopy was sensitive to changes in neovascularization during the progression of disease; both non-dysplastic and neoplastic Barrett's esophagus showed higher blood volume relative to healthy squamous tissue (P = 0.001 and 0.02, respectively), and vessel radius appeared larger in neoplasia relative to non-dysplastic Barrett's esophagus (P = 0.06). We further developed a deep learning algorithm capable of classifying spectra of neoplasia versus non-dysplastic Barrett's esophagus with high accuracy (84.8% accuracy, 83.7% sensitivity, 85.5% specificity, 78.3% positive predictive value, and 89.4% negative predictive value). Exploiting the newly acquired library of labeled spectra to model custom color filter sets identified a potential 12-fold enhancement in contrast between neoplasia and non-dysplastic Barrett's esophagus using application-specific color filters compared with standard-of-care white-light imaging (perceptible color difference = 32.4 and 2.7, respectively). This work demonstrates the potential of endoscopic spectral imaging to extract vascular properties in Barrett's esophagus, to classify disease stages using deep learning, and to enable high-contrast endoscopy. SIGNIFICANCE: The results of this pilot first-in-human clinical trial demonstrate the potential of spectral endoscopy to reveal disease-associated vascular changes and to provide high-contrast delineation of neoplasia in the esophagus. American Association for Cancer Research 2021-06-15 2021-05-26 /pmc/articles/PMC7611389/ /pubmed/34039635 http://dx.doi.org/10.1158/0008-5472.CAN-21-0474 Text en ©2021 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
spellingShingle Convergence and Technologies
Waterhouse, Dale J.
Januszewicz, Wladyslaw
Ali, Sharib
Fitzgerald, Rebecca C.
di Pietro, Massimiliano
Bohndiek, Sarah E.
Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title_full Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title_fullStr Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title_full_unstemmed Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title_short Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
title_sort spectral endoscopy enhances contrast for neoplasia in surveillance of barrett's esophagus
topic Convergence and Technologies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611389/
https://www.ncbi.nlm.nih.gov/pubmed/34039635
http://dx.doi.org/10.1158/0008-5472.CAN-21-0474
work_keys_str_mv AT waterhousedalej spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus
AT januszewiczwladyslaw spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus
AT alisharib spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus
AT fitzgeraldrebeccac spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus
AT dipietromassimiliano spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus
AT bohndieksarahe spectralendoscopyenhancescontrastforneoplasiainsurveillanceofbarrettsesophagus